The Clorox Company (NYSE:CLX) Shares Sold by Thomasville National Bank

Thomasville National Bank lessened its stake in The Clorox Company (NYSE:CLXFree Report) by 2.7% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 3,565 shares of the company’s stock after selling 100 shares during the period. Thomasville National Bank’s holdings in Clorox were worth $581,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the company. GoalVest Advisory LLC acquired a new position in Clorox during the 1st quarter worth about $31,000. First Foundation Advisors acquired a new position in shares of Clorox in the first quarter valued at approximately $31,000. Innealta Capital LLC purchased a new stake in Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC lifted its holdings in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares in the last quarter. Finally, Quarry LP boosted its position in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.51% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of several analyst reports. Wells Fargo & Company reduced their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. Citigroup lifted their price objective on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Barclays raised their target price on shares of Clorox from $130.00 to $137.00 and gave the company an “underweight” rating in a report on Friday. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday. Finally, JPMorgan Chase & Co. raised their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday. Six investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, Clorox currently has an average rating of “Hold” and a consensus target price of $150.14.

View Our Latest Report on Clorox

Clorox Price Performance

Shares of NYSE CLX opened at $161.59 on Tuesday. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The stock has a market cap of $20.07 billion, a P/E ratio of 83.73, a P/E/G ratio of 3.19 and a beta of 0.41. The stock has a 50 day moving average of $157.74 and a two-hundred day moving average of $144.78. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.09.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. On average, research analysts forecast that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.02%. Clorox’s payout ratio is 252.85%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.